Phase II Study of Preoperative IMRT Combined With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer
Latest Information Update: 27 Sep 2023
Price :
$35 *
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine (Primary)
- Indications Rectal cancer
- Focus Therapeutic Use
- 24 Jun 2013 New trial record